SERIES: Active Medical Product Surveillance Roundtables | Number 12 of 19 « Previous | Next »

Sep 21

Past Event

Brookings Roundtable on Active Medical Product Surveillance: Overivew of Additional Sentinel Activities

Event Materials


Brookings Multimedia content requires JavaScript. Your browser either doesn't have JavaScript or doesn't have it enabled.

Instructions to enable JavaScript.


The third and concluding webinar of the Sentinel Initiative 101 Series provided overviews of the Federal Partners Collaboration, the Observational Medical Outcomes Partnership (OMOP), and the Brookings Institution’s convening activities.

The webinar featured presentations from Melissa Robb, Project Director for the Sentinel Initiative, Office of Medical Policy, Center for Drug Evaluation and Research, U.S. Food and Drug Administration; Paul Stang, Senior Director of Epidemiology, Johnson & Johnson, and Principal Investigator at OMOP; and Josh Benner, Fellow in Economic Studies and Managing Director, Engelberg Center for Health Care Reform at Brookings. Presentations provided an overview of each activity and defined each activity’s role within the broader Sentinel Initiative.

Event Agenda

  • Welcome and Introduction

    • Judy Racoosin

      U.S. Food and Drug Administration

    • Paul Stang

      Johnson & Johnson and Observational Medical Outcomes Partnership


September 21, 2011

11:00 AM - 12:00 PM EDT

The Brookings Institution

Live Webinar

1775 Massachusetts Ave., NW


For More Information

Brookings Office of Communications

(202) 797-6105

SERIES: Active Medical Product Surveillance Roundtables | Number 12